Archive | August, 2013

Stocks Snap-Back After Sell-Off: NASDAQ Up 0.55%, ASTX Soars

But Uncertainty Clouds Intermediate Term Economic Outlook:  Oil prices, Emerging Markets, Russia and the FED Concerns about another Middle East war and a spike in oil prices waned a bit today but many “undertoads” remain such as weak economic data, taper talk, Q4 earnings and a slowdown in housing. So yesterday’s grim warnings about a […]

Continue Reading 0

Rayno Life Science Stocks: Deals Propel AMGN RGDX

Life science stocks resumed their upward trajectory today with major ETFs (FBT,IBB,XBI) up over 2% and a green screen for the sector. Mid-cap biopharma stocks are strong once again. The IBB hit an August low of $187 on August 19 after a high in early August near $201. Rayno Life Science stocks had two big […]

Continue Reading 0

NASDAQ Trades Halted on All Stocks 2 Hour Lockdown on NASDAQ Update

Update 8/26 Best idea on securities exchanges: Randall W.Forsyth in his Barron’s Up and Down Wall Street column recommends that the NASDAQ and NYSE are put under the watchful eye of the NSA. And while we are on “big data” there is news that Amazon (AMZN) has had problems with “Cloud” services management ————–. NASDAQ […]

Continue Reading 0

Biotechs Rally After FED Minutes-Sharp Comeback Update—- after close

Very Strange Whipsaw Day Who is in charge of this market, humans or computers?   Earlier: My biopharma screen has gone green. Maybe “taper light” scenario means buy biotech as macro and interest rates are not affected. More later but NASDAQ reversal to up 0.44%,  XBI up 2.5%, FBT up 3.4%, PCYC up 3.3% and […]

Continue Reading 0

Pure Play Diagnostic Companies-Metrics After Q2 Earnings: ALR, QDEL and TMO

Diagnostics Company Stocks Are Off Their 2013 Highs Life science tools and diagnostics stocks are near all time highs despite stretched valuations because of a strong secular biotech bull market and perceived synergy with biopharmaceuticals. Key themes are point of care testing, companion diagnostics and  molecular diagnostics. Here is a rundown of  the top 5 winners […]

Continue Reading 0

Pivotal Week Coming Up For Stocks: Can Technicals Hold With Little News?

Tempering, Tapering and Transition A mild sell-off shifted momentum to the bears last week as countercurrents and seasonality comes into play. Heavy vacations in August transition to Labor Day weekend, Jewish holidays then a pick up in trading by mid-September. Here are several events to ponder: Bond yields soared to 2.83 % up from the 1.6% […]

Continue Reading 0

Risk Off Resumes With Profit Taking-Biotechs Off 5% From Highs

Biotech Sector Momentum Quits-IBB at Support Level of $189 NASDAQ Off 1.73% to 3605 Have fund managers raised cash and gone on vacation? Moreover many weaker sectors have  become leaders like gold, silver,materials and energy. Walmart and Cisco are leading the way down against a back drop of stronger economic data.Over the past five days […]

Continue Reading 0

Rayno Life Science Portfolio: ILMN, PCYC, RGDX

Market Can’t Stay Down in Quiet Trading After a couple of lackluster trading days the market perked up as economic news continues positive with retail sales up for the  fourth consecutive month and many analysts believing Europe is coming out of recession. And the Icahn effect is back as Carl Icahn reveals his Apple (AAPL) […]

Continue Reading 0

Mixed Day Except Intrexon (XON) IPO Soars 54%

Intrexon (XON), a synthetic biology Company, focused in healthcare, animal science and agriculture raised over $160M in a Huge IPO . CEO Randall Kirk purchased 30M shares. Some pundits say this event punctuates the “golden age of biology”. This is the third successful Company for billionaire Kirk. JPMorgan and Barclays led the deal. Biocentury noted that 33 […]

Continue Reading 0

AACC Brief #2 Issues Arising-Reimbursement and Lab Developed Tests

The 2013 AACC (American Association for Clinical Chemistry) Meeting was attended by 650 exhibitors and over 17,000 professionals all looking to connect in the In Vitro Diagnostics (IVD) industry. For a complete up-to-date news and analysis of the industry check IVDNews. In this brief we will cover topics that were featured in the Plenary and […]

Continue Reading 0